Distinguishing Acetabulum Cup Retroversion From Anteversion on Anteroposterior Radiographs After Total Hip Arthroplasty

Sponsor
Taipei Medical University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04780100
Collaborator
(none)
20
2

Study Details

Study Description

Brief Summary

In this study, investigators will demonstrate and prove a ellipse method (Liaw's version) for measurement and detection of acetabulum cup retroversion.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Total hip arthroplasty (THA) is considered to be the best and most reliable treatment of end-stage hip disorders with satisfactory long-term clinical outcomes. However,the incidence of postoperative dislocation ranges from 0.3% to 3% in primary THA. The most important risk factor is malpositioning of implant components. Generally, excessive anteversion and retroversion increase risk of anterior and posterior hip dislocation respectively. Several radiological methods have been proposed to measure anteversion of the acetabular cup on plain radiographs, but most of these methods cannot accurately distinguish cup retroversion from anteversion. In this study, investigators will demonstrate and prove a ellipse method (Liaw's version) for measurement and detection of acetabulum cup retroversion.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    20 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Distinguishing Acetabulum Cup Retroversion From Anteversion on Anteroposterior Radiographs After Total Hip Arthroplasty
    Anticipated Study Start Date :
    Mar 1, 2021
    Anticipated Primary Completion Date :
    May 1, 2021
    Anticipated Study Completion Date :
    May 1, 2021

    Outcome Measures

    Primary Outcome Measures

    1. A computerized ellipse method (Liaw's version) for measurement and detection of acetabulum cup retroversion. [10 days]

      Total hip arthroplasty (THA) is considered to be the best and most reliable treatment of end-stage hip disorders with satisfactory long-term clinical outcomes. However,the incidence of postoperative dislocation ranges from 0.3% to 3% in primary THA. The most important risk factor is malpositioning of implant components. Generally, excessive anteversion and retroversion increase risk of anterior and posterior hip dislocation respectively. Several radiological methods have been proposed to measure anteversion of the acetabular cup on plain radiographs, but most of these methods cannot accurately distinguish cup retroversion from anteversion. In this article, we will demonstrate and prove a computerized ellipse method (Liaw's version) for measurement and detection of acetabulum cup retroversion.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    30 Years to 90 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Patients undergone total hip arthroplasty

    • Patients undergone total hip arthroplasty with more than two postoperative anteroposterior radiographs of pelvis

    • Patients undergone total hip arthroplasty with postoperative pelvic CT

    Exclusion Criteria:
    • Patients with congenital pelvis abnormality or pelvic fracture history

    • Patients with postoperative periprosthetic fracture(s)

    • Patients with postoperative infection or implants loosening

    • Patients undergone total hip arthroplasty without more than two postoperative anteroposterior radiographs of pelvis

    • Patients undergone total hip arthroplasty without postoperative pelvic CT

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Taipei Medical University

    Investigators

    • Study Chair: Chen-Kun Liaw, Taipei Medical University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Taipei Medical University
    ClinicalTrials.gov Identifier:
    NCT04780100
    Other Study ID Numbers:
    • N202005040
    First Posted:
    Mar 3, 2021
    Last Update Posted:
    Mar 3, 2021
    Last Verified:
    Jul 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Mar 3, 2021